The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients

Background: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of C...

Full description

Bibliographic Details
Main Authors: Yousif S. Alakeel, Ebtihal F. Alharbi, Haifa A. Alhaidal, Aisha M. Jumaa, Latifah K. Albaiahy, Noura S. Alsagami, Shatha A. Alshahrani
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034121004044
_version_ 1798026682690437120
author Yousif S. Alakeel
Ebtihal F. Alharbi
Haifa A. Alhaidal
Aisha M. Jumaa
Latifah K. Albaiahy
Noura S. Alsagami
Shatha A. Alshahrani
author_facet Yousif S. Alakeel
Ebtihal F. Alharbi
Haifa A. Alhaidal
Aisha M. Jumaa
Latifah K. Albaiahy
Noura S. Alsagami
Shatha A. Alshahrani
author_sort Yousif S. Alakeel
collection DOAJ
description Background: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of COVID-19. Materials and methods: This retrospective observational study was conducted from March 15 to October 23, 2020 and included data of all COVID-19 asthmatic patients (n = 287) at King Abdulaziz Medical City. Twelve patients were excluded due to poor medication history documentation or using ICS for non-asthma indication. Ordinal logistic regression was used to determine the clinical variables that affect COVID-19 severity. The clinical outcomes of ICS and non-ICS users were compared. Results: Of the sample (n = 275), 198 (72%) were using ICS therapy. No significant difference was found between ICS and non-ICS users in disease severity (P = 0.12), mortality (P = 0.45), ICU admission (P = 0.78), and the occurrence of complications. However, the number of days on ventilation were significantly increased in ICS users (P = 0.006). Being prescribed the ICS/LABA combination (adj OR: 0.72 [0.15,1.2]; P = 0.021), being hypertensive (adj OR: 0.98 [0.28,1.6]; P = 0.006), having cancer (adj OR: 1.49 [0.12, 2.8]; P = 0.033), or having diabetes (adj OR: 0.75 [0.09, 1.4]; P = 0.024) could not increase the risk for more severe disease. Conclusion: Overall, ICS therapy did not alter the COVID-19 severity or mortality in asthmatic patients. The continued use of ICS during the pandemic should be encouraged to prevent asthma exacerbations.
first_indexed 2024-04-11T18:39:22Z
format Article
id doaj.art-149288528cb04519be96bf4f87095b1f
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-04-11T18:39:22Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-149288528cb04519be96bf4f87095b1f2022-12-22T04:09:03ZengElsevierJournal of Infection and Public Health1876-03412022-01-011515664The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patientsYousif S. Alakeel0Ebtihal F. Alharbi1Haifa A. Alhaidal2Aisha M. Jumaa3Latifah K. Albaiahy4Noura S. Alsagami5Shatha A. Alshahrani6College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Corresponding author at: College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Respiratory Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaKing Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Applied Medical Sciences, Respiratory therapy Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaBackground: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids (ICS) by asthmatic patients and the severity of COVID-19. Materials and methods: This retrospective observational study was conducted from March 15 to October 23, 2020 and included data of all COVID-19 asthmatic patients (n = 287) at King Abdulaziz Medical City. Twelve patients were excluded due to poor medication history documentation or using ICS for non-asthma indication. Ordinal logistic regression was used to determine the clinical variables that affect COVID-19 severity. The clinical outcomes of ICS and non-ICS users were compared. Results: Of the sample (n = 275), 198 (72%) were using ICS therapy. No significant difference was found between ICS and non-ICS users in disease severity (P = 0.12), mortality (P = 0.45), ICU admission (P = 0.78), and the occurrence of complications. However, the number of days on ventilation were significantly increased in ICS users (P = 0.006). Being prescribed the ICS/LABA combination (adj OR: 0.72 [0.15,1.2]; P = 0.021), being hypertensive (adj OR: 0.98 [0.28,1.6]; P = 0.006), having cancer (adj OR: 1.49 [0.12, 2.8]; P = 0.033), or having diabetes (adj OR: 0.75 [0.09, 1.4]; P = 0.024) could not increase the risk for more severe disease. Conclusion: Overall, ICS therapy did not alter the COVID-19 severity or mortality in asthmatic patients. The continued use of ICS during the pandemic should be encouraged to prevent asthma exacerbations.http://www.sciencedirect.com/science/article/pii/S1876034121004044COVID-19AsthmaInhaled corticosteroidsViral infection
spellingShingle Yousif S. Alakeel
Ebtihal F. Alharbi
Haifa A. Alhaidal
Aisha M. Jumaa
Latifah K. Albaiahy
Noura S. Alsagami
Shatha A. Alshahrani
The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
Journal of Infection and Public Health
COVID-19
Asthma
Inhaled corticosteroids
Viral infection
title The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
title_full The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
title_fullStr The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
title_full_unstemmed The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
title_short The effects of the antecedent use of inhaled steroid on the clinical course of COVID-19: A retrospective study of asthmatic patients
title_sort effects of the antecedent use of inhaled steroid on the clinical course of covid 19 a retrospective study of asthmatic patients
topic COVID-19
Asthma
Inhaled corticosteroids
Viral infection
url http://www.sciencedirect.com/science/article/pii/S1876034121004044
work_keys_str_mv AT yousifsalakeel theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT ebtihalfalharbi theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT haifaaalhaidal theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT aishamjumaa theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT latifahkalbaiahy theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT nourasalsagami theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT shathaaalshahrani theeffectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT yousifsalakeel effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT ebtihalfalharbi effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT haifaaalhaidal effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT aishamjumaa effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT latifahkalbaiahy effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT nourasalsagami effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients
AT shathaaalshahrani effectsoftheantecedentuseofinhaledsteroidontheclinicalcourseofcovid19aretrospectivestudyofasthmaticpatients